Antiviral Drugs - Global Market Outlook (2016-2022)

  • ID: 4428364
  • Report
  • Region: Global
  • 148 pages
  • Stratistics Market Research Consulting Pvt Ltd
10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • AbbVie, Inc.
  • Aurobindo Pharma
  • Bristol-Myers-Squibb
  • Cipla
  • F. Hoffmann-La Roche AG
  • MORE
According to MRC, the Global Antiviral market is accounted for $42.65 billion in 2016 and is expected to reach $63.11 billion by 2022 growing at a CAGR of 5.8%. Increased count of people across the globe affecting from influenza, respiratory syncytial virus and epidemic of viral infections had given market a prudential base for the growth. Strong R&D and newer & advance formulations in the antiviral drugs market are expected to drive the market. However, high risk of failure and huge cost of R&D are hampering the market.

HIV antivirals segment among applications is expected to dominate the market due to increase in prevalence of HIV infections, and due to growing awareness among people. Moreover, generic drugs segment is expected to witness lucrative growth over the forecast period on account of favorable government regulations. North American market is expected to dominate the global market. However, Asia Pacific is estimated to be the fastest growing region due to growing economies and increased healthcare expenditure in the region.

Some of the key players of the Antiviral Drugs market include Abbott Laboratories, AbbVie, Inc., Aurobind-Pharma, Bristol-Myers-Squibb, Cipla, Dr. Reddy’s Laboratories Ltd., F. Hoffmann-La Roche AG, Gilead Sciences, GlaxoSmithKline plc., Johnson and Johnson, MedImmune/AstraZeneca, Merck & Co., Mylan N.V., Roche Diagnostics, Schering-Plough and Teva Pharmaceutical Industries Ltd.

Applications Covered:
  • Hepatitis-B antivirals
  • Hepatitis-C antivirals
  • Herpes virus
  • HIV antivirals
  • Influenza
  • Other Applications
  • Pneumonia
  • Flu
End-Users Covered:
  • Ambulatory Surgical Centers
  • Clinics
  • Hospitals
Distribution Channels Covered:
  • Hospital Pharmacy Store
  • Online Pharmacy
  • Retail Pharmacy Store
Types Covered:
  • Generic Drugs
  • Branded Drugs
Action Mechanisms Covered:
  • Nucleotide polymerase inhibitor
  • Protease inhibitors
  • Reverse transcriptase inhibitors
  • Other Action Mechanisms
Regions Covered:
  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • Italy
  • UK
  • Spain
  • Rest of Europe
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • Rest of Asia Pacific
  • Rest of the World
  • Middle East
  • Brazil
  • Argentina
  • South Africa
  • Egypt
What The Report Offers:
  • Market share assessments for the regional and country level segments
  • Market share analysis of the top industry players
  • Strategic recommendations for the new entrants
  • Market forecasts for a minimum of 6 years of all the mentioned segments, sub segments and the regional markets
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • AbbVie, Inc.
  • Aurobindo Pharma
  • Bristol-Myers-Squibb
  • Cipla
  • F. Hoffmann-La Roche AG
  • MORE
1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 Product Analysis
3.8 Emerging Markets
3.9 Futuristic Market Scenario

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Antiviral Drugs Market, By Application
5.1 Introduction
5.2 Hepatitis-B antivirals
5.3 Hepatitis-C antivirals
5.4 Herpes virus
5.5 HIV antivirals
5.6 Influenza
5.7 Other Applications
5.7.1 Pneumonia
5.7.2 Flu

6 Global Antiviral Drugs Market, By End-User
6.1 Introduction
6.2 Ambulatory Surgical Centers
6.3 Clinics
6.4 Hospitals

7 Global Antiviral Drugs Market, By Distribution Channels
7.1 Introduction
7.2 Hospital Pharmacy Store
7.3 Online Pharmacy
7.4 Retail Pharmacy Store

8 Global Antiviral Drugs Market, By Product Type
8.1 Introduction
8.2 Generic Drugs
8.3 Branded Drugs

9 Global Antiviral Drugs Market, By Action Mechanism
9.1 Introduction
9.2 Nucleotide polymerase inhibitor
9.3 Protease inhibitors
9.4 Reverse transcriptase inhibitors
9.5 Other Action Mechanisms

10 Global Antiviral Drugs Market, By Geography
10.1 North America
10.1.1 US
10.1.2 Canada
10.1.3 Mexico
10.2 Europe
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 UK
10.2.5 Spain
10.2.6 Rest of Europe
10.3 Asia Pacific
10.3.1 Japan
10.3.2 China
10.3.3 India
10.3.4 Australia
10.3.5 New Zealand
10.3.6 Rest of Asia Pacific
10.4 Rest of the World
10.4.1 Middle East
10.4.2 Brazil
10.4.3 Argentina
10.4.4 South Africa
10.4.5 Egypt

11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies

12 Company Profiling
12.1 Abbott Laboratories
12.2 AbbVie, Inc.
12.3 Aurobindo Pharma
12.4 Bristol-Myers-Squibb
12.5 Cipla
12.6 Dr. Reddy’s Laboratories Ltd
12.7 F. Hoffmann-La Roche AG
12.8 Gilead Sciences
12.9 GlaxoSmithKline plc.
12.10 Johnson and Johnson
12.11 MedImmune/AstraZeneca
12.12 Merck & Co
12.13 Mylan N.V.
12.14 Roche Diagnostics
12.15 Schering-Plough
12.16 Teva Pharmaceutical Industries Ltd.

List of Tables

Table 1 Global Antiviral Drugs Market Outlook, By Region (2014-2022) ($MN)
Table 2 Global Antiviral Drugs Market Outlook, By Application (2014-2022) ($MN)
Table 3 Global Antiviral Drugs Market Outlook, By Hepatitis-B antivirals (2014-2022) ($MN)
Table 4 Global Antiviral Drugs Market Outlook, By Hepatitis-C antivirals (2014-2022) ($MN)
Table 5 Global Antiviral Drugs Market Outlook, By Herpes virus (2014-2022) ($MN)
Table 6 Global Antiviral Drugs Market Outlook, By HIV antivirals (2014-2022) ($MN)
Table 7 Global Antiviral Drugs Market Outlook, By Influenza (2014-2022) ($MN)
Table 8 Global Antiviral Drugs Market Outlook, By Other Applications (2014-2022) ($MN)
Table 9 Global Antiviral Drugs Market Outlook, By Pneumonia (2014-2022) ($MN)
Table 10 Global Antiviral Drugs Market Outlook, By Flu (2014-2022) ($MN)
Table 11 Global Antiviral Drugs Market Outlook, By End-Users (2014-2022) ($MN)
Table 12 Global Antiviral Drugs Market Outlook, By Ambulatory Surgical Centers (2014-2022) ($MN)
Table 13 Global Antiviral Drugs Market Outlook, By Clinics (2014-2022) ($MN)
Table 14 Global Antiviral Drugs Market Outlook, By Hospitals (2014-2022) ($MN)
Table 15 Global Antiviral Drugs Market Outlook, By Distribution Channels (2014-2022) ($MN)
Table 16 Global Antiviral Drugs Market Outlook, By Hospital Pharmacy Store (2014-2022) ($MN)
Table 17 Global Antiviral Drugs Market Outlook, By Online Pharmacy (2014-2022) ($MN)
Table 18 Global Antiviral Drugs Market Outlook, By Retail Pharmacy Store (2014-2022) ($MN)
Table 19 Global Antiviral Drugs Market Outlook, By Product Type (2014-2022) ($MN)
Table 20 Global Antiviral Drugs Market Outlook, By Generic Drugs (2014-2022) ($MN)
Table 21 Global Antiviral Drugs Market Outlook, By Branded Drugs (2014-2022) ($MN)
Table 22 Global Antiviral Drugs Market Outlook, By Action Mechanism (2014-2022) ($MN)
Table 23 Global Antiviral Drugs Market Outlook, By Nucleotide polymerase inhibitor (2014-2022) ($MN)
Table 24 Global Antiviral Drugs Market Outlook, By Protease inhibitors (2014-2022) ($MN)
Table 25 Global Antiviral Drugs Market Outlook, By Reverse transcriptase inhibitors (2014-2022) ($MN)
Table 26 Global Antiviral Drugs Market Outlook, By Other Action Mechanisms (2014-2022) ($MN)
Table 27 North America Antiviral Drugs Market Outlook, By Country (2014-2022) ($MN)
Table 28 North America Antiviral Drugs Market Outlook, By Application (2014-2022) ($MN)
Table 29 North America Antiviral Drugs Market Outlook, By Hepatitis-B antivirals (2014-2022) ($MN)
Table 30 North America Antiviral Drugs Market Outlook, By Hepatitis-C antivirals (2014-2022) ($MN)
Table 31 North America Antiviral Drugs Market Outlook, By Herpes virus (2014-2022) ($MN)
Table 32 North America Antiviral Drugs Market Outlook, By HIV antivirals (2014-2022) ($MN)
Table 33 North America Antiviral Drugs Market Outlook, By Influenza (2014-2022) ($MN)
Table 34 North America Antiviral Drugs Market Outlook, By Other Applications (2014-2022) ($MN)
Table 35 North America Antiviral Drugs Market Outlook, By Pneumonia (2014-2022) ($MN)
Table 36 North America Antiviral Drugs Market Outlook, By Flu (2014-2022) ($MN)
Table 37 North America Antiviral Drugs Market Outlook, By End-Users (2014-2022) ($MN)
Table 38 North America Antiviral Drugs Market Outlook, By Ambulatory Surgical Centers (2014-2022) ($MN)
Table 39 North America Antiviral Drugs Market Outlook, By Clinics (2014-2022) ($MN)
Table 40 North America Antiviral Drugs Market Outlook, By Hospitals (2014-2022) ($MN)
Table 41 North America Antiviral Drugs Market Outlook, By Distribution Channels (2014-2022) ($MN)
Table 42 North America Antiviral Drugs Market Outlook, By Hospital Pharmacy Store (2014-2022) ($MN)
Table 43 North America Antiviral Drugs Market Outlook, By Online Pharmacy (2014-2022) ($MN)
Table 44 North America Antiviral Drugs Market Outlook, By Retail Pharmacy Store (2014-2022) ($MN)
Table 45 North America Antiviral Drugs Market Outlook, By Product Type (2014-2022) ($MN)
Table 46 North America Antiviral Drugs Market Outlook, By Generic Drugs (2014-2022) ($MN)
Table 47 North America Antiviral Drugs Market Outlook, By Branded Drugs (2014-2022) ($MN)
Table 48 North America Antiviral Drugs Market Outlook, By Action Mechanism (2014-2022) ($MN)
Table 49 North America Antiviral Drugs Market Outlook, By Nucleotide polymerase inhibitor (2014-2022) ($MN)
Table 50 North America Antiviral Drugs Market Outlook, By Protease inhibitors (2014-2022) ($MN)
Table 51 North America Antiviral Drugs Market Outlook, By Reverse transcriptase inhibitors (2014-2022) ($MN)
Table 52 North America Antiviral Drugs Market Outlook, By Other Action Mechanisms (2014-2022) ($MN)
Table 53 Europe Antiviral Drugs Market Outlook, By Country (2014-2022) ($MN)
Table 54 Europe Antiviral Drugs Market Outlook, By Application (2014-2022) ($MN)
Table 55 Europe Antiviral Drugs Market Outlook, By Hepatitis-B antivirals (2014-2022) ($MN)
Table 56 Europe Antiviral Drugs Market Outlook, By Hepatitis-C antivirals (2014-2022) ($MN)
Table 57 Europe Antiviral Drugs Market Outlook, By Herpes virus (2014-2022) ($MN)
Table 58 Europe Antiviral Drugs Market Outlook, By HIV antivirals (2014-2022) ($MN)
Table 59 Europe Antiviral Drugs Market Outlook, By Influenza (2014-2022) ($MN)
Table 60 Europe Antiviral Drugs Market Outlook, By Other Applications (2014-2022) ($MN)
Table 61 Europe Antiviral Drugs Market Outlook, By Pneumonia (2014-2022) ($MN)
Table 62 Europe Antiviral Drugs Market Outlook, By Flu (2014-2022) ($MN)
Table 63 Europe Antiviral Drugs Market Outlook, By End-Users (2014-2022) ($MN)
Table 64 Europe Antiviral Drugs Market Outlook, By Ambulatory Surgical Centers (2014-2022) ($MN)
Table 65 Europe Antiviral Drugs Market Outlook, By Clinics (2014-2022) ($MN)
Table 66 Europe Antiviral Drugs Market Outlook, By Hospitals (2014-2022) ($MN)
Table 67 Europe Antiviral Drugs Market Outlook, By Distribution Channels (2014-2022) ($MN)
Table 68 Europe Antiviral Drugs Market Outlook, By Hospital Pharmacy Store (2014-2022) ($MN)
Table 69 Europe Antiviral Drugs Market Outlook, By Online Pharmacy (2014-2022) ($MN)
Table 70 Europe Antiviral Drugs Market Outlook, By Retail Pharmacy Store (2014-2022) ($MN)
Table 71 Europe Antiviral Drugs Market Outlook, By Product Type (2014-2022) ($MN)
Table 72 Europe Antiviral Drugs Market Outlook, By Generic Drugs (2014-2022) ($MN)
Table 73 Europe Antiviral Drugs Market Outlook, By Branded Drugs (2014-2022) ($MN)
Table 74 Europe Antiviral Drugs Market Outlook, By Action Mechanism (2014-2022) ($MN)
Table 75 Europe Antiviral Drugs Market Outlook, By Nucleotide polymerase inhibitor (2014-2022) ($MN)
Table 76 Europe Antiviral Drugs Market Outlook, By Protease inhibitors (2014-2022) ($MN)
Table 77 Europe Antiviral Drugs Market Outlook, By Reverse transcriptase inhibitors (2014-2022) ($MN)
Table 78 Europe Antiviral Drugs Market Outlook, By Other Action Mechanisms (2014-2022) ($MN)
Table 79 Asia Pacific Antiviral Drugs Market Outlook, By Country (2014-2022) ($MN)
Table 80 Asia Pacific Antiviral Drugs Market Outlook, By Application (2014-2022) ($MN)
Table 81 Asia Pacific Antiviral Drugs Market Outlook, By Hepatitis-B antivirals (2014-2022) ($MN)
Table 82 Asia Pacific Antiviral Drugs Market Outlook, By Hepatitis-C antivirals (2014-2022) ($MN)
Table 83 Asia Pacific Antiviral Drugs Market Outlook, By Herpes virus (2014-2022) ($MN)
Table 84 Asia Pacific Antiviral Drugs Market Outlook, By HIV antivirals (2014-2022) ($MN)
Table 85 Asia Pacific Antiviral Drugs Market Outlook, By Influenza (2014-2022) ($MN)
Table 86 Asia Pacific Antiviral Drugs Market Outlook, By Other Applications (2014-2022) ($MN)
Table 87 Asia Pacific Antiviral Drugs Market Outlook, By Pneumonia (2014-2022) ($MN)
Table 88 Asia Pacific Antiviral Drugs Market Outlook, By Flu (2014-2022) ($MN)
Table 89 Asia Pacific Antiviral Drugs Market Outlook, By End-Users (2014-2022) ($MN)
Table 90 Asia Pacific Antiviral Drugs Market Outlook, By Ambulatory Surgical Centers (2014-2022) ($MN)
Table 91 Asia Pacific Antiviral Drugs Market Outlook, By Clinics (2014-2022) ($MN)
Table 92 Asia Pacific Antiviral Drugs Market Outlook, By Hospitals (2014-2022) ($MN)
Table 93 Asia Pacific Antiviral Drugs Market Outlook, By Distribution Channels (2014-2022) ($MN)
Table 94 Asia Pacific Antiviral Drugs Market Outlook, By Hospital Pharmacy Store (2014-2022) ($MN)
Table 95 Asia Pacific Antiviral Drugs Market Outlook, By Online Pharmacy (2014-2022) ($MN)
Table 96 Asia Pacific Antiviral Drugs Market Outlook, By Retail Pharmacy Store (2014-2022) ($MN)
Table 97 Asia Pacific Antiviral Drugs Market Outlook, By Product Type (2014-2022) ($MN)
Table 98 Asia Pacific Antiviral Drugs Market Outlook, By Generic Drugs (2014-2022) ($MN)
Table 99 Asia Pacific Antiviral Drugs Market Outlook, By Branded Drugs (2014-2022) ($MN)
Table 100 Asia Pacific Antiviral Drugs Market Outlook, By Action Mechanism (2014-2022) ($MN)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott Laboratories
  • AbbVie, Inc.
  • Aurobindo Pharma
  • Bristol-Myers-Squibb
  • Cipla
  • Dr. Reddy’s Laboratories Ltd
  • F. Hoffmann-La Roche AG
  • Gilead Sciences
  • GlaxoSmithKline plc.
  • Johnson and Johnson
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll